Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
204 Cards in this Set
- Front
- Back
Anatomy of the kidney:
|
|
|
Gross picture of renal infarct:
|
Recent on left, old scarred on the right.
|
|
CT scan of a renal infarct:
|
Shows area where there is no blood flow. BUT, this will not tell you when it happened, it could be recent or old...
Typically, a renal infarct causes no pain, unless the capsule is involved - this is because there are no pain fibers in the parenchyma. |
|
Two causes of a renal infarction:
|
|
|
Renal vein thrombosis:
|
|
|
Renal artery stenosis:
|
The main complication of stenosis is renal vascular hypertension
|
|
Pathway to hypertension from renal artery stenosis:
|
|
|
Gross and histology of ischemic nephropathy:
|
|
|
|
B: fibromuscular dysplasia with "beads on a string appearance"
|
|
Renal artery atherosclerosis:
|
|
|
Renal fibromuscular dysplasia:
|
|
|
Renal atheroembolic disease:
|
Can lead to renal failure in older adults.
|
|
Systemic complications of atheroembolic disease:
|
|
|
Papillary Necrosis:
|
|
|
Benign Nephrosclerosis:
|
|
|
Histology of benign nephrosclerosis:
|
|
|
Malignant Nephrosclerosis:
|
Happens rapidly
|
|
Gross kidney with malignant nephrosclerosis:
|
|
|
Histology of malignant nephrosclerosis:
|
|
|
|
Typical presentation in childhood.
|
|
Typical findings in all forms of thrombotic MA:
|
Caused by HUS and TTP
|
|
Pathogenesis of HUS:
|
|
|
Pathogenesis of TTP:
|
|
|
Comparison between HUS and TTP
|
|
|
Henoch-Scholnein Purpura:
|
Rash primary on the legs and the buttocks
|
|
on a patient with Henoch-Scholnein Purpura?
|
Mesangial hypercellularity
|
|
Causes of renal agenesis:
|
|
|
Unilateral renal agenesis:
|
|
|
Abnormalities associated with unilateral renal agenesis:
|
|
|
Prognosis of patients with unilateral renal agenesis:
|
|
|
Bilateral renal agenesis:
|
|
|
Potter's Syndrome:
|
|
|
Prognosis of patients with bilateral renal agenesis:
|
|
|
Multicystic dysplastic kidney:
|
|
|
Supernumerary Kidneys:
|
|
|
Ureteral Duplication:
|
|
|
Ureteral Duplication part 2:
|
|
|
Complications of ureteral duplication:
|
|
|
Embryology of kidney ascent:
|
|
|
Locations of renal ectopia (ascent problems):
|
|
|
Presentation of renal ectopia:
|
|
|
Horseshoe Kidney:
|
|
|
Horseshoe kidney associated anomalies:
|
|
|
Horseshoe kidney associated anomalies part 2:
|
|
|
Complete renal fusion:
|
|
|
Ureter obstruction associated with multiple renal arteries:
|
|
|
Kidney stone formation risk factors:
|
|
|
Types of urinary crystals:
|
|
|
What type of kidney stone is the most common?
|
Calcium oxalate
accounts for 70-80% of all kidney stones. |
|
Risk factors for calcium oxalate stone formation:
|
|
|
Uric Acid stone formation risk factors:
|
|
|
Struvite stone formation:
|
|
|
Cysteine stone formation:
|
|
|
Kidney stone locations; three points of concern:
|
|
|
Kidney stone presentation:
|
|
|
Presenting symptoms of kidney stones part 2:
|
|
|
Kidney stone differential diagnosis:
|
Hydronephrosis = swelling of the kidney
|
|
Kidney stone CT scan diagnosis:
|
|
|
Intital treatment of kidney stones:
|
Sympatholytic and CCB relax smooth muscle around ureters and help pass the stone.
|
|
Time required for passage of a kidney stone:
|
|
|
Indications for surgery to remove a kidney stone:
|
|
|
Lithotripsy for kidney stone treatment:
|
|
|
Evaluation of metabolic factors in a patient with kidney stones:
|
|
|
What does tea contain that makes it a risk factor for kidney stones?
|
Oxalate
|
|
What type of kidney stone would you likely see in a patient with a high urine pH?
|
Struvite; due to the urea splitting bacteria leading to production of alkalinizing ammonia
|
|
In a patient with calcium oxalate stones, why would you not want them to quit taking calcium supplements?
|
Oral calcium will bind to oxalate in the gut and lead to decreased absorption of oxalate.
Also, without calcium to bind to oxalate in the urine, oxalate will form a nadus on which to build kidney stones. It is better to have calcium and oxalate bind together to be able to be flushed out in the urine better. |
|
What is a Randal's plaque made out of?
|
Calcium phosphate
|
|
Urinary tract obstruction:
|
|
|
|
|
|
Microscopy findings with urinary tract obstruction:
|
|
|
Gross photo of a chronically obstructed kidney:
|
|
|
Histology of chronic urinary obstruction:
|
Note thinning of the renal parenchyma
|
|
Initial findings in urinary tract obstruction:
|
|
|
Clinical findings in urinary tract obstruction:
|
|
|
Causes of UTO:
|
|
|
Diagram of locations of UTO causes:
|
|
|
Uretopelvic junction obstruction:
|
Happens if the ureter lacks the normal peristaltic function
|
|
Cause of uretopelvic juction obstruction in adults:
|
Patient will have pain after drinking lots of fluid, then the pain will go away as the patient becomes more dehydrated
|
|
UPJ presentation in infants and children:
|
|
|
Urinary reflux:
|
|
|
Ureterovesical junction:
|
The ureter does not enter the bladder at a right angle; it goes through a submucosal tunnel first
|
|
Grading of reflux severity:
|
|
|
Reflux complications:
|
|
|
Reflux epidemiology:
|
|
|
Developmental anomalies associated with reflux:
|
|
|
Inheritance pattern of reflux:
|
|
|
Primary vs Secondary reflux:
|
|
|
Causes of secondary reflux:
|
|
|
Ureterocele:
|
|
|
Voiding cystourethrogram for diagnosis of reflux:
|
|
|
Antibiotic management of reflux:
|
|
|
Indications for surgical treatment of reflux:
|
|
|
Renal cysts:
|
|
|
Polycystic kidney disease nomeclature:
|
|
|
Recessive PKD:
|
|
|
Onset of cysts in recessive PKD:
|
Kidney shape is preserved, but it is enlarged.
|
|
What in utero disorder can recessive PKD lead to?
|
Potter's syndrome
|
|
Liver involvement in recessive PKD:
|
|
|
What two diseases will patients with recessive PKD develop at some point in their life?
|
Renal failure, congestive heart failure or both
|
|
Dominant PKD:
|
|
|
Inheritance patterns of dominant PKD:
|
|
|
Pathology of dominant PKD:
|
Dominant PKD can affect any portion of the nephron unit, whereas recessive PKD only affects the tubules.
|
|
Dominant PKD related mortality:
|
|
|
Other GI manifestations of dominant PKD:
|
|
|
Cardiovascular manifestations of dominant PKD:
|
|
|
Renal/urinary manifestations of dominant PKD:
|
|
|
What is important to control in dominant PKD patients?
|
|
|
Tuberous sclerosis; another syndrome that can be caused by mutations responsible for ADPKD:
|
|
|
Tuberous Sclerosis:
|
An angiomyolyoma can be a risk factor for developing renal cell carcinoma
|
|
Incidence of simple cysts according to age:
|
A non-genetic disease
|
|
Multicystic dysplastic kidney:
|
Caused by the failure of the ureter to enter the bladder. Kidney makes urine but it has nowhere to go - causing cysts.
|
|
Acquired renal cystic disease:
|
|
|
Findings in acquired renal cystic disease:
|
|
|
Complications associated with acquired renal cystic disease:
|
|
|
Urinary incontinence definitions:
|
|
|
Is incontinence more common in men or women?
|
|
|
Physiology of urination:
|
|
|
Physiology of urination part 2:
|
|
|
What are risk factors for stress incontinence?
|
Obesity, multiparity, smoking, pelvic surgery, menopause and constipation
|
|
What are some risk factors for urge incontinence?
|
|
|
Important history to get when evaluating incontinence:
|
|
|
Examinations to perform when evaluating incontinence:
|
|
|
Labs and studies to get when evaluating incontinence:
|
|
|
Treatment options for stress incontinence:
|
|
|
Treatment options for urge incontinence:
|
|
|
Benign adult renal tumors:
|
|
|
|
|
|
|
Papillary, collecting duct, clear cell and chromophobe (in order)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Things to remember about renal clear cell carcinoma:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rests are peices of embryological tissue sitting among normal tissue
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transitional cell bladder cancer pearls:
|
|
|
In an asymptomatic patient, what bacterial count is needed to diagnose a UTI?
|
At least 10 to the 5th power.
With a symptomatic patient, a lower count is acceptable. |
|
Cystitis vs. Urethritis:
|
|
|
Pyelonephritis:
|
|
|
Uncomplicated vs. complicated UTI:
|
|
|
Pathobiology of UTI's:
|
|
|
Pathobiology of UTI's part 2:
|
|
|
Common causative agents of UTI's:
|
|
|
Common causative agents of complicated UTI's:
|
|
|
Catheters and nosocomial UTI's:
|
|
|
Indications for catheter use:
|
|
|
Pyelonephritis gross picture:
|
Microabscesses
|
|
Is there a connection between chronic UTI's and chronic kidney disease?
|
|
|
|
Chronic pyelonephritis caused by VU reflux leads to damaged compound papilla.
Chronic pyelonephritis caused by obstruction leads to both compound and simple papilla damage. |
|
Gross kidney as a result of chronic pyelonephritis with obstruction:
|
|
|
Histology of kidney with chronic infection damage vs. normal:
|
|
|
Diagram of potassium homeostasis:
|
The colon is where K+ gets excreted through the fecal route.
|
|
Reabsorption of potassium through the tubules:
|
The distal tubule is the only site where potassium reabsorption or excretion is regulated.
|
|
Major factors in potassium regulation:
|
|
|
Causes of spurious hyperkalemia:
|
Spurious = lab result is high, but in reality the patients potassium level is normal
|
|
If the lab reports a patient's K+ as 7.0 with hemolysis, what should you do?
|
Get an EKG first to check...then have the blood re-drawn.
* The K+ value may actually be high even without the hemolysis. |
|
Causes of external balance hyperkalemia:
|
|
|
Causes of internal balance hyperkalemia:
|
|
|
Hyper/Hypokalemia and membrane potential:
|
|
|
Hyperkalemia and it's effect on the heart:
|
|
|
Causes of external hypokalemia:
|
|
|
Causes of internal hypokalemia:
|
|
|
Effects of hypokalemia on the EKG:
|
|
|
Systemic effects of chronic hypokalemia:
|
|
|
Urine potassium algorithm for determining renal vs. non-renal causes of imbalance:
|
|
|
Serum sodium measurements relate directly to water in the ECF:
|
|
|
Osmoregulation vs. Volume regulation mechanisms:
|
|
|
Total body water calculation:
|
|
|
Fluid compartment rules:
|
|
|
What is the difference between tonicity and osmolarity?
|
Tonicity is osmoles that can make the cell shrink or swell - not every osmole can do that.
*The most important thing that determines tonicity in the body is sodium* |
|
The difference between tonicity and osmolality:
|
|
|
The effect of tonicity on red blood cells:
|
|
|
Hyponatremia:
|
|
|
Algorithm for determing causes of hyponatremia:
|
|
|
The effect of hyponatremia and it's correction on the brain:
|
|
|
Hypernatremia:
|
|
|
Serum osmolarity thresholds for ADH release and thirst:
|
|
|
Diabetes Insipidus:
|
|
|
Causes of diabetes insipidus:
|
|
|
Symptoms of hypertonicity:
|
|
|
Consequences of hypertonicity:
|
|
|
Treatment of hypernatremia:
|
|
|
In a patient with severe life threatening hyperkalemia, what are the first steps you should take to correct the high K+?
|
Insulin + glucose
Calcium to stabilize the myocardium Loop diuretics |
|
Treatment of hyperkalemia:
|
|
|
Low magnesium can cause wasting of what electrolyte from the kidney?
|
Potassium!
|
|
Times required for buffering acid/base changes:
|
|
|
Renal excretion of acids:
|
|
|
Renal Acid Transporters:
|
|
|
Interpretation of the urine anion gap:
|
|